1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsi3 Accelerator is sponsored by Mount Sinai Innovation Partners (MSIP). The i3 Accelerator provides milestone-based funding for more established healthcare technologies with potential for commercial translation. Researchers collaborate with MSIP to execute a project strategy to advance technologies beyond the lab bench.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
i3 Funding - Mount Sinai Innovation Partners Discover what the i3 Family of Funds offers to Mount Sinai innovators. Discover what the i3 Family of Funds offers to Mount Sinai innovators. Frequently Asked Questions Launched by MSIP, the i3 Family of Funds offers a variety of technology commercialization funding for Mount Sinai innovators.
“i3” stands for innovation , inflection , and impact , the three ingredients necessary to expediate commercializing relevant inventions and transforming a research idea into a mature, commercial-ready technology. There are three different opportunities that make up the Family, with different criteria in an effort to enable a wide range of inventors from Mount Sinai’s research and clinical communities.
Learn more about each opportunity below. Get to know the three opportunities that make up the i3 Family of Funds: i3 Prism, i3 Genesis, and i3 Accelerator. i3 Prism aims to foster innovators and innovations that have not been previously awarded significant funding, to expand the pool of early-stage health care solutions in Mount Sinai’s commercialization pipeline.
Selected applicants will receive up to $33K in funding, which will be distributed based on the achievement of milestones. Types of Eligible Technologies: Technologies from all healthcare fields are acceptable, including, but not limited to: therapeutics, diagnostics, medical devices, and digital health. Application Process: Innovators who meet the eligibility criteria can submit a proposal during the time period above.
Submitted proposals will be distributed for review among Mount Sinai experts to be scored based on project feasibility and market risks against the budget and milestones provided. Learn More About i3 Prism i3 Genesis is the inaugural funding program for early-stage healthcare technologies at Mount Sinai with clear potential for commercialization.
This program aims to support and translate innovations by providing funding to achieve value inflection points. Types of Eligible Technologies: Technologies from all healthcare fields are acceptable, including, but not limited to: therapeutics, diagnostics, medical devices, and digital health. Application Process: Innovators must meet the eligibility criteria .
Learn More About i3 Genesis i3 Accelerator advances the development of discoveries from Mount Sinai into groundbreaking technologies that aim to help the patient population. The goal is to increase the pace of commercialization for a promising technology by applying a strategic and milestone-driven investment. Researchers collaborate with MSIP to execute a project strategy to advance technologies beyond the lab bench.
Types of Eligible Technologies: Technologies from all healthcare fields are acceptable, including, but not limited to: therapeutics, diagnostics, medical devices, and digital health. Application Process: i3 Accelerator projects must be nominated by MSIP’s Business Development (BD) representatives. Innovators must meet the eligibility criteria .
Learn More About i3 Accelerator Frequently Asked Questions How does each i3 opportunity differ? i3 Accelerator (launched in 2018): milestone-based funding for more established healthcare technologies with potential for commercial translation after the completion of milestones.
i3 Genesis (launched in January 2022): funding for early-stage healthcare discoveries with the potential to become commercialized, with an objective to generate proof-of-concept data. i3 Prism (launching March 2022): funding for technology commercialization efforts by innovators to advance early-stage technologies. Can projects include more than one PI?
i3 Prism , i3 Genesis , and i3 Accelerator can include multiple PIs, as long as they are part of Mount Sinai (e.g. faculty, staff, postdoc, etc.). Please visit the respective program pages to learn more. Who can I contact for more information?
For inquiries about i3 Genesis and i3 Accelerator, please reach out to Louise Lammers, PhD, Director, Business Development, Emerging Assets at louise. lammers@mssm. edu and William Chiang, PhD, Business Development Consultant, at william.
chiang@mssm. edu . For inquiries about i3 Prism, please reach out to Steffanie Haripersaud, MHA, Program Manager, at steffanie.
haripersaud@mssm. edu . Can I submit the same project to both i3 Genesis and i3 Prism?
At this time, i3 Genesis funding is not available. Typically, applicants can submit the same project as long as the development plans fit the criteria for the funds and the applicant meets the eligibility requirements. Please keep in mind that if you get awarded i3 Genesis funding, you are no longer eligible for i3 Prism funding.
Mount Sinai Health System The Mount Sinai Health System is an integrated health care system providing exceptional medical care to our local and global communities. For technology and research inquiries: visit Contact Your Representative or Contact MSIP Non-Discrimination Notice Research Cores, Data, and Technology Frequently Asked Questions (FAQs) Explore Career Opportunities Mount Sinai Health System Hit enter to search or ESC to close
According to the current listing, eligibility includes: Mount Sinai innovators with more established healthcare technologies that have commercial translation potential. Projects must be nominated by MSIP's Business Development representatives. Confirm the full requirements in the official notice before applying.
i3 Accelerator is funded by Mount Sinai Innovation Partners (MSIP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Schmidt Marine Technology Partners funds the development and deployment of ocean technology — sustainable fisheries, ocean observation, habitat restoration, and pollution — with grants typically $100,000 to $400,000. The initial proposal window closes July 31, 2026. Here's what makes this funder different and how to write for it.
Read articleThe FWS Coastal Program (F26AS00069) and Partners for Fish and Wildlife (F26AS00068) close September 30, 2026 with a combined $21 million and 650 anticipated awards. Both list broad eligibility and zero cost share. Both also require contact with a local program office before you write a word — which makes this a FY2027 positioning story, not an October deadline story.
Read articleThe Common Investment Initial Screening Application went live July 24, 2026, routing a single submission to 14 federal financing partners including DFC, ExIm, and the Office of Strategic Capital. Outside estimates put the accessible capacity above half a trillion dollars. It is also the most consequential unscored application in federal funding — no deadline, no review criteria, no commitment, and disclosure obligations most applicants will not read carefully. Here is how it actually works.
Read article